TCON Report

TRACON Pharmaceuticals, Inc.
Stock Exchange: NASDAQ
Sector: healthcare
2.72
Last session price
2.72
Price now
Currency: USD
Reporting currency: USD
ISIN: US89237H2094
INN:
.

TCON financial statements

* Numbers in thousands
Year
 2014 2015 2016 2017 2018 2019 2020 TTM
Capitalization *
 112 588 84 924 60 854 49 578 21 826 12 865 96 054 28 585
EV *
 86 522 52 393 32 607 27 551 3 117 1 796 69 777 69 777
Stock price $
 94 76.4 48 29.5 8.1 4.24 9.14 2.72
Number of shares *
 1 198 1 112 1 268 1 681 2 695 3 034 10 509 10 509
EPS
 -5,68 -21,96 -21,30 -11,37 -12,97 -7,47 -1,60 -1,60
Revenue *
 3 598 7 904 3 449 8 755 3 000 0 0 0
Net income *
 -6 809 -24 410 -27 008 -19 103 -34 959 -22 674 -16 775 -16 775
Operating profit *
 -6 179 -23 467 -25 976 -18 210 -34 740 -22 296 -16 223 -16 223
Total liabilities *
 70 345 22 544 17 394 19 143 19 206 15 423 12 366 12 366
Net debt *
 -26 066 -32 531 -28 247 -22 027 -18 709 -11 069 -26 277 -26 277
Total assets *
 38 171 53 522 45 730 36 130 40 648 18 121 36 930 36 930
Equity *
 -32 174 30 978 28 336 16 987 21 442 2 698 25 072 25 072
Cash and investments *
 35 000 52 156 44 413 34 466 39 104 16 412 36 130 36 130

Over the past 10 years, the maximum capitalization of TRACON Pharmaceuticals, Inc. is 112 588, the minimum is 12 865.
Maximum net income 0, Minimum net income -34 959.
The maximum price of TCON shares is 94, the minimum price is 4.24.

.

TCON valuation

Year
 2014 2015 2016 2017 2018 2019 2020 TTM
P/E
 -16,54 -3,48 -2,25 -2,60 -0,62 -0,57 -5,73 -1,70
P/B
 -3,50 2,74 2,15 2,92 1,02 4,77 3,83 1,14
P/S
 31,29 10,74 17,64 5,66 7,28 0,00 0,00 0,00
E/P
 -6% -29% -44% -39% -160% -176% -17% -59%
P/FCF
 66,70 -4,40 -2,24 -3,73 -0,71 -0,54 -5,63 -1,68
.

TCON profitability

Year
 2014 2015 2016 2017 2018 2019 2020 TTM
ROE
 21% -79% -95% -112% -163% -840% -67%
ROA
 -18% -46% -59% -53% -86% -125% -45%
ROIC
 -25% -60% -73% -75% -128% -355% -61%